Jordi Mestres, coordinator
of the IMIM and UPF research group on Systems Pharmacology at the Biomedical Informatics Program (GRIB) states «With this study we have contributed to complementing the detection
of these quite unstable fragments, with information on the mechanism
of action
of the drug, based on three aspects: similarity to other medicines, prediction
of their
pharmacological profile, and interference with specific biological pathways.